Medical News
Addiction
Allergies
Alternative Medicine
Asthma
Cancer
Cardiology
Chiropractic
Dental
Dermatology
Diabetes
Emergency
Family Medicine
General
Geriatrics
Hospitals
Infectious Diseases
Internal Medicine
Managed Care / HMO
Medical Products
Mental Health
Neurology
Nursing
Nutrition
OB / GYN
Pediatrics
Pharmaceuticals
Physical Therapy
Plastic Surgery
Psychology
Radiology / Imaging
Research
Sports Medicine
Surgery
Vision

TrialStat's ESRNexus Links Specific Search Results to Trial Recruitment Through ClinicalTrials.gov

SRS integration with ESRNexus is complete.

Ottawa, ON (PRWEB) September 13, 2007 -- TrialStat Corporation, a clinical data solutions on demand company, today bolstered the search capabilities of ESRNexus™ by incorporating up-to-date clinical trial recruitment postings from ClinicalTrials.gov. Developed by the National Library of Medicine, ClinicalTrials.gov posts public and private-sector sponsored recruitment listings for clinical trials. ClinicalTrials.gov has recruitment notifications for more than 41,000 clinical studies and receives more than 20 million page views per month. ESRNexus users, for example, can now search reference abstracts on lung cancer research, while simultaneously reviewing clinical trial recruitment postings on the disease from ClinicalTrials.gov.    

In addition, TrialStat has finalized the integration between SRS™, the company’s Web-based systematic review solution, and ESRNexus. By linking their accounts to ESRNexus, SRS users can import articles directly from their ESRNexus clipboards to their SRS-based systematic review. Users can also share systematic review protocols and reference articles by publishing them to ESRNexus. SRS is the world’s only Web-based commercial solution designed to streamline the screening and data extraction phases of systematic reviews.

“ESRNexus now provides a single destination for medical literature search and clinical trial recruitment listings,” said Peter O’Blenis, Vice President Systematic Reviews, TrialStat. “For the general public, this combination represents a trusted, peer reviewed resource for both published and ongoing clinical research. Systematic reviewers, meanwhile, using SRS have the ability to share their coded information through ESRNexus simply and easily through our integration of the two products.”

ESRNexus enables users to search, share and re-use references, and manually extract data from peer-reviewed reference literature, such as academic journals. Using TrialStat’s SRS 4.0, users can codify general information from journal articles, which they can then publish to ESRNexus through an easy-to-use wizard. Since its beta launch, the literature search engine has more than 250,000 reference contributions from leading academic institutions.

With contributions from Stanford University, McMaster University and the University of Central Florida – among others – ESRNexus provides information that has been organized, reviewed and tagged by professional researchers. Key goals of ESRNexus are to reduce the cost of ongoing research through data sharing and reuse and to provide health care consumers with an easy-to-use, free and trusted source of peer-reviewed reference material.

ABOUT TRIALSTAT
TrialStat Corporation provides innovative clinical data solutions on demand that optimize the collection and management of research to enable customers to accelerate the commercialization of new life science products. ClinicalAnalytics 4.0™ is a robust and scaleable Web-based EDC on demand platform used by leading biopharma organizations. SRS 4.0 automates systematic reviews using real-time collaboration and management tools, while ESRNexus (www.esrnexus.com) is the most comprehensive and free Web-based search engine for evidence-based reference literature. More information about TrialStat is available at www.trialstat.com.

ClinicalAnalytics 4.0, SRS 4.0 and ESRNexus are registered trademarks of TrialStat Corporation.

Contact:
Chris Wright
TrialStat Corporation
613-741-9909 x155

# # #

Simillar Articles

TrialStat Executive to Speak at Adaptive Clinical Trial Designs Conference
TrialStat Corporation ( www.trialstat.com ), a clinical data solutions on demand company, today announced that Khaled El Emam, the company’s Chief Scientist, will speak at the Adaptive...
TrialStat Executive to Speak at E-Clinical Trials in Canada Conference
TrialStat Corporation, the industry's first clinical data solutions on demand company, today continued to shape discussion around adaptive clinical trials by participating in the E-Clinical...
Innovaderm Research Inc. Joins TrialStat's CROFirst Program
Montreal-based Contract Research Organization (CRO) Deploys ClinicalAnalytics 4.0 for its Clinical Trials
TrialStat CEO to Speak at C-TECH Clinical Technologies Congress
TrialStat Corporation today announced that Jonathan Barker, the company’s President and CEO will speak at the C-TECH Clinical Technologies Congress in Philadelphia, Pennsylvania on Tuesday,...
TrialStat CEO Jonathan Barker to Speak at Clinical Trials Congress in Las Vegas, Nevada February 7
Jonathan Barker, President and CEO of TrialStat, will speak at the Clinical Trials Congress (CTC) in Las Vegas on February 7 where he will discuss why electronic data capture (EDC) must change to...
Home Terms of Use Privacy Policy Contact Us